Sickle cell disease

Annarita Miccio receives 1st prize of the Paris Region Innovators Award 2023 for her work on hemoglobinopathies

A new tool to correct a mutation in beta-thalassemia

“The systematic screening of sickle cell disease extended to the entire French population is a real victory”

First successes and new approaches in gene therapy

CRISPR-Cas9, molecular scissors at the service of the gene therapies of tomorrow : interview from Dr. Annarita Miccio, lab director at the Imagine Institute, Paris

D201801 – Study of erythropoiesis and circulating red blood cells in gene therapy for sickle cell disease

Wassim El Nemer

D201704 – Acquisition of a new generation sequencer

Pr. Stanislas Lyonnet

D201703 – New gene therapy strategy for sickle cell disease using umbilical cord blood

Anne Galy

D201702 – Preclinical development of new lentiviral vectors and gene therapy strategies to treat sickle cell disease

Annarita Miccio

D201701- Development of new therapeutic strategies in sickle cell disease

Pr. Pablo Bartolucci